Suberoylanilide hydroxamic acid represses glioma stem-like cells

[1]  Huidong Shi,et al.  Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth. , 2016, Cancer research.

[2]  M. Narita,et al.  Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition , 2015, Molecular biology of the cell.

[3]  J. Rich,et al.  Cancer stem cells in glioblastoma , 2015, Genes & development.

[4]  M. Suzuki,et al.  Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays , 2015, International journal of radiation biology.

[5]  C. Wahlestedt,et al.  Emerging treatment strategies for glioblastoma multiforme , 2014, EMBO molecular medicine.

[6]  G. Maira,et al.  Isolation of Cancer Stem Cells from Three Human Glioblastoma Cell Lines: Characterization of Two Selected Clones , 2014, PloS one.

[7]  A. Holoubek,et al.  Decitabine and SAHA-Induced Apoptosis Is Accompanied by Survivin Downregulation and Potentiated by ATRA in p53-Deficient Cells , 2014, Oxidative medicine and cellular longevity.

[8]  S. Pan,et al.  Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells. , 2014, Journal of medicinal chemistry.

[9]  Atique U. Ahmed,et al.  Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy , 2014, Cell Death and Differentiation.

[10]  C. Blanpain,et al.  Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.

[11]  Weijun Su,et al.  Induction of p38δ Expression Plays an Essential Role in Oncogenic ras-Induced Senescence , 2013, Molecular and Cellular Biology.

[12]  J. Nör,et al.  Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck Cancer , 2013, PloS one.

[13]  Sungpil Yoon,et al.  Molecular Mechanism of SAHA on Regulation of Autophagic Cell Death in Tamoxifen-Resistant MCF-7 Breast Cancer Cells , 2012, International journal of medical sciences.

[14]  Y. Suh,et al.  c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells , 2012, Oncogene.

[15]  S. Kalkanis,et al.  Glioblastoma cell line-derived spheres in serum‑containing medium versus serum-free medium: a comparison of cancer stem cell properties. , 2012, International journal of oncology.

[16]  M. Czyz,et al.  Sphere formation and self-renewal capacity of melanoma cells is affected by the microenvironment , 2012, Melanoma research.

[17]  P. Nelson,et al.  Cellular senescence and cancer chemotherapy resistance. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[18]  U. Moll,et al.  SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis , 2011, Cell Death and Differentiation.

[19]  G. Stein,et al.  Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts. , 2011, Bone.

[20]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[21]  David F Jarrard,et al.  Therapy-induced senescence in cancer. , 2010, Journal of the National Cancer Institute.

[22]  A. Krešo,et al.  Cancer Stem Cells and Self-renewal , 2010, Clinical Cancer Research.

[23]  P. Meltzer,et al.  Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks , 2009, Clinical Cancer Research.

[24]  O. Witt,et al.  HDAC family: What are the cancer relevant targets? , 2009, Cancer letters.

[25]  M. Verdier,et al.  Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis. , 2009, International journal of oncology.

[26]  R. Bjerkvig,et al.  DNA repair and cancer stem-like cells--potential partners in glioma drug resistance? , 2008, Cancer treatment reviews.

[27]  X. Bian,et al.  Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. , 2008, Cancer letters.

[28]  P. Dirks,et al.  Brain tumor stem cells: bringing order to the chaos of brain cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  A. Kung,et al.  Anti-apoptosis mechanisms in malignant gliomas. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  X. Bian,et al.  [Isolation and identification of tumor stem-like cells from human glioma cell line U87 after treatment of vincristine]. , 2007, Ai zheng = Aizheng = Chinese journal of cancer.

[31]  P. Marks,et al.  Histone Deacetylase Inhibitors: Overview and Perspectives , 2007, Molecular Cancer Research.

[32]  J. Campisi,et al.  Cellular senescence: when bad things happen to good cells , 2007, Nature Reviews Molecular Cell Biology.

[33]  Keith L Black,et al.  Suberoylanilide Hydroxamic Acid, a Histone Deacetylase Inhibitor: Effects on Gene Expression and Growth of Glioma Cells In vitro and In vivo , 2007, Clinical Cancer Research.

[34]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[35]  Ronald W. Lewis,et al.  SAHA‐sensitized prostate cancer cells to TNFα‐related apoptosis‐inducing ligand (TRAIL): Mechanisms leading to synergistic apoptosis , 2006, International journal of cancer.

[36]  A. Rivera,et al.  Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/ M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells , 2006, Cellular and Molecular Life Sciences CMLS.

[37]  N. Gueven,et al.  The complexity of p53 stabilization and activation , 2006, Cell Death and Differentiation.

[38]  G. Perez,et al.  Induction of polyploidy by histone deacetylase inhibitor: a pathway for antitumor effects. , 2005, Cancer research.

[39]  R. Weinberg,et al.  The signals and pathways activating cellular senescence. , 2005, The international journal of biochemistry & cell biology.

[40]  J. Shay,et al.  Senescence and immortalization: role of telomeres and telomerase. , 2005, Carcinogenesis.

[41]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[42]  A. Rebbaa.  Targeting senescence pathways to reverse drug resistance in cancer. , 2005, Cancer letters.

[43]  Sean J Morrison,et al.  Bmi1, stem cells, and senescence regulation. , 2004, The Journal of clinical investigation.

[44]  R. Maestro,et al.  Role of Caspases, Bid, and p53 in the Apoptotic Response Triggered by Histone Deacetylase Inhibitors Trichostatin-A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA)* , 2003, Journal of Biological Chemistry.

[45]  Jiahuai Han,et al.  Mitogen‐activated protein kinase p38 defines the common senescence‐signalling pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[46]  S. Volinia,et al.  The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults , 2002, Nature.

[47]  Albert J. Fornace,et al.  Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.

[48]  E. Appella,et al.  Post-translational modifications and activation of p53 by genotoxic stresses. , 2001, European journal of biochemistry.

[49]  T. Unger,et al.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 , 1999, The EMBO journal.

[50]  Liwu Fu,et al.  Targeting cancer stem cells: a new therapy to cure cancer patients. , 2012, American journal of cancer research.

[51]  Chunlei Zhang,et al.  Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). , 2007, Blood.